EPIX Key Statistics, Chart & Performance
The current stock price of EPIX is 0.2012 USD. In the past month the price decreased by -1.85%. In the past year, price decreased by -96.77%.
EPIX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 24.18 | 403.83B | ||
| AMGN | AMGEN INC | 14.97 | 176.25B | ||
| GILD | GILEAD SCIENCES INC | 14.99 | 152.28B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 26.12 | 115.03B | ||
| REGN | REGENERON PHARMACEUTICALS | 17.15 | 81.12B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 779.71 | 52.53B | ||
| INSM | INSMED INC | N/A | 37.12B | ||
| NTRA | NATERA INC | N/A | 31.62B | ||
| BIIB | BIOGEN INC | 10.51 | 25.82B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.46 | 20.98B | ||
| INCY | INCYTE CORP | 15.38 | 19.39B | ||
| EXAS | EXACT SCIENCES CORP | N/A | 19.27B |
Related stock screener links
About EPIX
Company Profile
ESSA is a pharmaceutical company focused on the development of small molecule drugs for the treatment of cancer, with a focus on advanced prostate cancer. The company is headquartered in Vancouver, British Columbia and currently employs 35 full-time employees. The company went IPO on 2021-02-22. The firm is undergoing a comprehensive review process to review its strategic options to maximize shareholder value.
Company Info
ESSA Pharma Inc
999 West Broadway, Suite 720
Vancouver BRITISH COLUMBIA V5Z 1K5 CA
CEO: David Parkinson
Employees: 35
Phone: 17783310962
ESSA Pharma Inc / EPIX FAQ
What does ESSA Pharma Inc do?
ESSA is a pharmaceutical company focused on the development of small molecule drugs for the treatment of cancer, with a focus on advanced prostate cancer. The company is headquartered in Vancouver, British Columbia and currently employs 35 full-time employees. The company went IPO on 2021-02-22. The firm is undergoing a comprehensive review process to review its strategic options to maximize shareholder value.
What is the current price of EPIX stock?
The current stock price of EPIX is 0.2012 USD. The price decreased by -1.85% in the last trading session.
Does ESSA Pharma Inc pay dividends?
EPIX does not pay a dividend.
How is the ChartMill rating for ESSA Pharma Inc?
EPIX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the GICS sector and industry of EPIX stock?
ESSA Pharma Inc (EPIX) operates in the Health Care sector and the Biotechnology industry.
Can you provide the number of employees for ESSA Pharma Inc?
ESSA Pharma Inc (EPIX) currently has 35 employees.
Can you provide the ownership details for EPIX stock?
You can find the ownership structure of ESSA Pharma Inc (EPIX) on the Ownership tab.
EPIX Technical Analysis
EPIX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to EPIX. No worries on liquidiy or solvency for EPIX as it has an excellent financial health rating, but there are worries on the profitability.
EPIX Financial Highlights
Over the last trailing twelve months EPIX reported a non-GAAP Earnings per Share(EPS) of -0.64. The EPS decreased by -6.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -22.73% | ||
| ROE | -23.07% | ||
| Debt/Equity | 0 |
EPIX Forecast & Estimates
7 analysts have analysed EPIX and the average price target is 1.73 USD. This implies a price increase of 761.83% is expected in the next year compared to the current price of 0.2012.